if they license out 2591 for multiple indications that’ll make an acquisition a very slim chance
- Forums
- ASX - By Stock
- Ann: Neuren receives Rare Pediatric Disease Designation from FDA
if they license out 2591 for multiple indications that’ll make...
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.48 |
Change
0.270(1.78%) |
Mkt cap ! $1.976B |
Open | High | Low | Value | Volume |
$15.19 | $15.57 | $15.11 | $2.994M | 193.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 278 | $15.47 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.48 | 110 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 711 | 15.430 |
7 | 742 | 15.420 |
4 | 534 | 15.410 |
7 | 800 | 15.400 |
4 | 738 | 15.390 |
Price($) | Vol. | No. |
---|---|---|
15.450 | 196 | 1 |
15.460 | 412 | 3 |
15.470 | 399 | 4 |
15.480 | 1358 | 6 |
15.490 | 946 | 6 |
Last trade - 12.14pm 23/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online